F‐MWNT‐ANG exhibited enhanced uptake in the glioma brain compared to the non‐targeted conjugate, demonstrating the potential of ANG‐conjugated f‐MWNTs for effective drug delivery to brain malignancies. Here, ANG is linked to central nervous system cancer.